Log In
Print
BCIQ
Print
Print this Print this
 

ATH008

  Manage Alerts
Collapse Summary General Information
Company Advancell Advanced In Vitro Cell Technologies S.A.
DescriptionUndisclosed topical cream
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationHand-foot syndrome
Indication DetailsTreat hand-foot skin reactions (HFSR); Treat palmar-plantar erythrodysesthesia syndrome (PPES) (hand-foot syndrome)
Regulatory Designation

Partner

Helsinn Healthcare S.A.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today